Related Experiment Videos
External beam radiation monotherapy for prostate cancer
Summary
External beam radiation monotherapy shows favorable outcomes for early prostate cancer. For advanced stages, pelvic lymphadenectomy aids patient selection for improved disease-free survival.
Area of Science:
- Oncology
- Radiation Oncology
- Urologic Oncology
Background:
- Investigating external beam radiation monotherapy for localized prostate cancer.
- Clarifying long-term outcomes and prognostic factors.
Purpose of the Study:
- Evaluate the efficacy and limitations of radiation monotherapy in prostate cancer.
- Identify prognostic indicators for treatment success.
Main Methods:
- Retrospective analysis of 91 patients treated with external beam radiation therapy (1976-1994).
- Staging included T categories (T1b-T3) and pelvic lymphadenectomy (pN0-pNX).
- Radiation delivered via Linac X-rays, fast neutron, or combination; endocrine therapy used at relapse.
Main Results:
- 10-year local control: 74.0%; disease-free survival: 49.6%.
- T category, pN category, and histologic grade were significant univariate predictors of disease-free survival.
- T category was an independent prognostic factor; pN0/1 patients with T2b/T3 disease had better survival than pNX.
Conclusions:
- External beam radiation monotherapy yields favorable long-term outcomes for minimally advanced prostate cancer (T1b, T2a).
- Staging pelvic lymphadenectomy is valuable for selecting patients with locally advanced disease (T2b, T3).